Abbott Labs Swings to Loss After Booking Charge on Mylan Stake

Abbott Laboratories swung to a loss in the most recent quarter as it booked a hefty charge related to the stock-price drop of embattled EpiPen maker Mylan NV, in which it owns a stake.

Source: WSJ.com: Health - October 20, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news